Widening the Framework for Regulation of Dual-Use Research in the Wake of the COVID-19 Pandemic   [open pdf - 0B]

From the Executive Summary: "In the wake of the COVID-19 [coronavirus disease 2019] pandemic, the global scientific community has directed increased resources and attention towards the study of viruses and emergency medical countermeasure development. Our analysis of publicly available data on publications, preprints, and clinical trials coupled with the Global Health Security Index [GHSI] measure of dual-use oversight suggests that some research activities raise dual-use concerns that have gone unaddressed. [...] We argue that certain categories of research that receive more attention following a pandemic pose unique dual-use risks that must be addressed by a comprehensive approach involving: 1) a broader definition of dual-use research of concern that captures experimental techniques that could feasibly be translated to harmful pathogens. 2) creation of regulatory frameworks to oversee the funding and publication of dual-use experiments, especially in countries with large biomedical research output and countries where the GHSI has highlighted shortcomings in national dual-use policies. These policy changes must also be accompanied by stronger social norms among grant makers and scientists alike, in order to effectively address biosecurity concerns in advance of the next outbreak."

American Biological Safety Association
Retrieved From:
ABSA International: https://absa.org/
Media Type:
Help with citations